UK Health Security Agency (UKHSA)

Public institution / office


Location: London, United Kingdom (GB) GB

ROR: https://ror.org/018h10037

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Publisher Correction: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (Scientific Reports, (2023), 13, 1, (21291), 10.1038/s41598-023-48738-6) (2024) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article, Erratum Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (2023) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article The HBM4EU chromates study – Outcomes and impacts on EU policies and occupational health practices (2023) Santonen T, Louro H, Bocca B, Bousoumah R, Duca RC, Fucic A, Galea KS, et al. Journal article, Review article Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model (2023) Schmidt A, Paudyal B, Villanueva-Hernández S, Mcnee A, Vatzia E, Carr BV, Schmidt S, et al. Journal article Time Trends of Acrylamide Exposure in Europe: Combined Analysis of Published Reports and Current HBM4EU Studies (2022) Poteser M, Laguzzi F, Schettgen T, Vogel N, Weber T, Zimmermann P, Hahn D, et al. Journal article Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000-2021) (2022) Poteser M, Laguzzi F, Schettgen T, Vogel N, Weber T, Murawski A, Schmidt P, et al. Journal article